AKBA
Akebia Therapeutics, Inc. · Healthcare · Market cap $253.7M
Insiders sold $62K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Jul 1, 2026
Insider Buying
$87K
reported purchases (SEC code P)
Insider Selling
$963K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Aug 10, 2026
Ostrowski Erik
Akebia Therapeutics, Inc. (AKBA) has 21 SEC Form 4 filings (31 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 10, 2026.
Inside the rolling window, 6 insiders at Akebia Therapeutics, Inc. reported 1 open-market purchase totaling $87K and 7 open-market sales totaling $963K. The most recent open-market filing is a sale of 56,019 shares by SVP, CFO, CBO & Treasurer Ostrowski Erik, dated Jun 29, 2026, worth $62K.
- Industry:Biotechnology
- CEO:John Butler
- Employees:194
- HQ:Cambridge, MA, US
- IPO:2014-03-20
| Source | |||||||
|---|---|---|---|---|---|---|---|
Ostrowski ErikFirst in 5 months | SVP, CFO, CBO & Treasurer | Sale | 56,019 | $62K | Jul 1 | -24.3% | SEC ↗ |
| CEO and President | Purchase | 69,270 | $87K | Mar 5 | -23.1% | SEC ↗ | |
Butler John P.First filing | CEO and President | Sale | 341,305 | $474K | Feb 4 | -33.2% | SEC ↗ |
Burke Steven KeithFirst filing | SVP, Chief Medical Officer | Sale | 67,658 | $94K | Feb 4 | -33.2% | SEC ↗ |
Rucci Carolyn M.First filing | SVP, Chief Legal Officer | Sale | 69,772 | $97K | Feb 4 | -33.2% | SEC ↗ |
Malabre Richard CFirst filing | SVP, Chief Accounting Officer | Sale | 49,524 | $69K | Feb 4 | — | SEC ↗ |
Grund NicholasFirst filing | Chief Commercial Officer | Sale | 84,829 | $118K | Feb 4 | — | SEC ↗ |
Ostrowski ErikFirst filing | SVP, CFO, CBO & Treasurer | Sale | 34,951 | $49K | Feb 4 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does AKBA have?
Akebia Therapeutics, Inc. (AKBA) has 21 SEC Form 4 filings (31 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Aug 10, 2026.
When was the most recent SEC Form 4 filing for AKBA?
The most recent Form 4 filing for AKBA on Tracefour is dated Aug 10, 2026.
What is the net insider flow at AKBA over the last 6 months?
Over the trailing 180 days, insiders at AKBA have net bought $24K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AKBA in the current window?
Inside the rolling window, insiders at AKBA bought $87K and sold $963K based on SEC Form 4 filings.
Can I get alerts for AKBA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Akebia Therapeutics, Inc. (AKBA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Akebia Therapeutics, Inc. is in the Healthcare sector.